{
  "url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.25/division-2/division-B",
  "json_url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.25/division-2/division-B.json",
  "legislation": "eudn/2018/945",
  "legislation_title": "Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2018-945",
  "path": "annex/II/division/3/division/3.25/division/2/division/B",
  "kind": "division",
  "number": "B",
  "heading": "Probable case",
  "text": "Pleocytosis in cerebrospinal fluid AND positive Lyme borreliosis serology in cerebrospinal fluid\nOR\nSpecific intrathecal Lyme borreliosis antibody production",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.25/division/2/division/B",
    "retrieved_at": "2026-11-01T15:13:03.598650+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}